Now for the best vaccine, and one that will give us lasting immunity
A lot of lives are going to be saved by early Covid-19 vaccines, but the US can do better with proper research answering the many questions remaining
If there is a common theme in the errors of the US response to Covid-19, it has been the astounding amount of squandering. Our leaders squandered time, as well as public trust and people’s economic and emotional resources. And they squandered the chance to do good science — testing drugs and vaccines in a way that serves the public interest rather than the interest of pharmaceutical companies.
There is no question that Covid-19 vaccines and therapies will save many lives. But we are not doing the kind of scientific study needed to determine the best vaccines and therapies to maximise lives saved and minimise the weeks we endure unprecedented social and economic constraints. It is not too late to change course...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.